News Releases

July 2019

July 1, 2019 7/1/2019 Takeda Completes Sale of XIIDRA® to Novartis

June 2019

June 28, 2019 6/28/2019 Takeda Announces New Assignments of Directors

June 27, 2019 6/27/2019 Takeda Announces the Publication of its Annual Report on Form 20-F for FY2018

June 26, 2019 6/26/2019 Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR)

June 25, 2019 6/25/2019 Takeda Announces Baxalta’s Commencement of Consent Solicitation with Respect to Baxalta’s 3.600% Senior Notes due 2022, 4.000% Senior Notes due 2025, 5.250% Senior Notes due 2045

June 5, 2019 6/5/2019 Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial

June 3, 2019 6/3/2019 Takeda Presents Results from Lung Portfolio

June 3, 2019 6/3/2019 New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase

June 3, 2019 6/3/2019 Takeda Makes First Private Sector Pledge for Global Fund Replenishment

・For legacy Shire information, click here